J
J. Donald Easton
Researcher at University of California, San Francisco
Publications - 113
Citations - 22677
J. Donald Easton is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Stroke & Aspirin. The author has an hindex of 42, co-authored 104 publications receiving 20175 citations. Previous affiliations of J. Donald Easton include Brown University & Stanford University.
Papers
More filters
Journal ArticleDOI
Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial.
K.S. Lawrence Wong,Pierre Amarenco,Gregory W. Albers,Hans Denison,J. Donald Easton,Scott R. Evans,Peter Held,Anders Himmelmann,Scott E. Kasner,Mikael Knutsson,Per Ladenvall,Kazuo Minematsu,Carlos A. Molina,Yongjun Wang,S. Claiborne Johnston,Investigators +15 more
TL;DR: In this secondary analysis from SOCRATES, fewer primary end points occurred on ticagrelor treatment than on aspirin in patients receiving aspirin before randomization, but there was no significant treatment-by-prior-aspirin interaction.
Journal ArticleDOI
Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups.
Hans-Christoph Diener,Ralph L. Sacco,J. Donald Easton,Christopher B. Granger,Michal Bar,Richard A. Bernstein,Michael Brainin,Martina Brueckmann,Martina Brueckmann,Lisa Cronin,Geoffrey A. Donnan,Zuzana Gdovinova,Claudia Grauer,Eva Kleine,Timothy Kleinig,Philippe Lyrer,Sheila C Martins,Juliane Meyerhoff,Truman J. Milling,Waltraud Pfeilschifter,Sven Poli,Michal Reif,David Z. Rose,Daniel Šaňák,Wolf Rüdiger Schäbitz +24 more
TL;DR: Subgroup analyses of RE-SPECT ESUS reduced the rate of recurrent stroke compared with aspirin in patients qualifying for the lower dose of dabigatran, and aspirin remains the standard antithrombotic treatment for patients with embolic stroke of undetermined source.
Journal ArticleDOI
Risk for Cardiovascular Outcomes among Subjects with Atherosclerotic Cardiovascular Disease and Greater-than-Normal Estimated Glomerular Filtration Rate
Jula K. Inrig,Barbara S. Gillespie,Uptal D. Patel,Libbie P. Briley,Lilin She,J. Donald Easton,Eric J. Topol,Lynda A. Szczech +7 more
TL;DR: In individuals with a history of vascular disease, the relationship between eGFR and cardiovascular outcomes may be parabolic, with increased risk among patients with both reduced and elevated eG FR.
Journal ArticleDOI
Clopidogrel Plus Aspirin for Stroke Prevention
Mark J. Alberts,J. Donald Easton +1 more
TL;DR: The results of the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study are viewed as more supportive of the combination of clopIDogrel plus aspirin in stroke-threatened patients.
Journal ArticleDOI
Benefit of Clopidogrel in Patients with Evidence of Cerebrovascular Disease
TL;DR: In this paper, the effect of clopidogrel in patients with previous cerebrovascular disease was examined in patients who were at risk of vascular ischemic events.